FDA Advisors' COIs; Ongoing Ukraine Heart Transplants; N.J. Cardiologist's $2M Fraud
(MedPage Today) -- It turns out the FDA advisory committee charged with reviewing the TriClip G4 had multiple financial ties to Abbott, the device manufacturer, creating a question of potential conflicts of interest (COI). (KFF Health News) FDA... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 16, 2024 Category: Cardiology Source Type: news

After Adverse Pregnancy Outcomes, Mortality Risk Lingers for Decades
(MedPage Today) -- Women who experienced major adverse pregnancy outcomes still had increased mortality risks decades later, a population-based cohort study of Swedish data found. Adverse pregnancy outcomes independently associated with increased... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 15, 2024 Category: Cardiology Source Type: news

Persistent Non-HDL-C Dyslipidemia Starting in Childhood Tied to Higher CVD Risk
(MedPage Today) -- Patients with persistent non-high-density lipoprotein (HDL) cholesterol dyslipidemia from childhood to adulthood had an increased risk of cardiovascular disease (CVD) events, but those who had resolved this by adulthood had a... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 12, 2024 Category: Cardiology Source Type: news

CDC: COVID Vax Not Linked to Sudden Deaths in Young Adults
(MedPage Today) -- The hunt for a signal of excess sudden cardiac deaths among young people after COVID-19 vaccination left Oregon health officials empty-handed, they reported. Investigators searched death certificates for Oregon residents 16... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 11, 2024 Category: Cardiology Source Type: news

Shockwave Therapy Shows Benefit in Lower Limb Claudication
(MedPage Today) -- Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little benefit from that standard... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 10, 2024 Category: Cardiology Source Type: news

FFR-Guided Complete Revascularization Did Not Improve Outcomes in MI Patients
(MedPage Today) -- ATLANTA -- Fractional flow reserve (FFR)-guided complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease did not result in better outcomes compared... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 10, 2024 Category: Cardiology Source Type: news

Novel Biannual Antihypertensive Shows Potential for Combination Therapy
(MedPage Today) -- ATLANTA -- The novel RNA silencer zilebesiran reduced blood pressure (BP) when added to a diuretic, calcium channel blocker, or maximum-dose angiotensin receptor blocker, the phase II KARDIA-2 trial showed. At 3 months, the... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 10, 2024 Category: Cardiology Source Type: news

Radial Cath Kits Recalled; siRNAs for Lipid Lowering; Smartphone HF Detection
(MedPage Today) -- Gamification of daily step goals and financial incentives resulted in increased physical activity over 1 year. (Circulation) Ambulatory heart rate varies widely between healthy middle-aged individuals and cannot be predicted... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 9, 2024 Category: Cardiology Source Type: news

Oral Appliance for Sleep Apnea Noninferior to CPAP for Reducing Arterial BP
(MedPage Today) -- ATLANTA -- An oral appliance for people with obstructive sleep apnea (OSA) was noninferior to continuous positive airway pressure (CPAP) for reducing 24-hour mean arterial blood pressure (BP) in patients with hypertension and... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 9, 2024 Category: Cardiology Source Type: news

Third-Generation PCSK9 Inhibitor Cuts Cholesterol With Single, Small, Monthly Shot
(MedPage Today) -- ATLANTA -- A novel PCSK9 inhibitor safely reduced LDL cholesterol levels with just a single, quick, once-monthly dose, the phase III LIBerate-HR trial showed. Lerodalcibep reduced LDL cholesterol by 56% more than placebo from... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 9, 2024 Category: Cardiology Source Type: news

Early Win for Preemptive Stents on Vulnerable Coronary Plaque
(MedPage Today) -- ATLANTA -- The concept of using stents to seal off non-flow-limiting vulnerable plaques, before they have a chance to rupture, worked out in the first major trial testing this provocative idea. Compared with standard medical... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 9, 2024 Category: Cardiology Source Type: news

Self-Selection for Statin Appears Safe, Effective
(MedPage Today) -- ATLANTA -- The vast majority of people correctly identified their own need for a statin using a web tool and took the drug appropriately without a prescription, according to an actual use study, supporting the safety of approval... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news

With Ticagrelor, Aspirin May Not Be Needed After PCI for Acute Coronary Syndrome
(MedPage Today) -- ATLANTA -- In select patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndromes who were event-free for 1 month on dual antiplatelet therapy (DAPT), treatment with ticagrelor (Brilinta) alone... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news

Coronary Sinus Implant Proves Symptom Relief Benefit in Refractory Angina
(MedPage Today) -- ATLANTA -- For people with stable coronary artery disease and refractory angina, a coronary sinus reducer (CSR) implant showed a symptom alleviation benefit in the small placebo-controlled ORBITA-COSMIC trial. The number of... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news

Apolipoprotein A1 Infusions After Acute MI Disappoint in Phase III Trial
(MedPage Today) -- ATLANTA -- Plasma-derived human apolipoprotein A1 (CSL112) infusions failed to improve outcomes for acute myocardial infarction (MI) patients with multivessel coronary artery disease and other cardiovascular risk factors, the... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 8, 2024 Category: Cardiology Source Type: news